Paris | Reuters — Bayer’s Monsanto division on Wednesday lost a final appeal in a long-running French legal battle in which the crop chemical maker has been held liable for a farmer’s accidental ...
A case against Bayer’s Monsanto unit was overturned in a Washington state appeals court this month. A $185 million verdict against Pharmacia—a Monsanto spinoff—which sold now-banned chemicals called ...
Today, a decision was issued by the Court of Appeals Division I in the State of Washington in Erickson v. Monsanto, ruling in Monsanto's favor on multiple grounds. This decision reverses the ...
SAN FRANCISCO (CN) — Bayer urged a federal judge on Friday to scuttle a class action from investors claiming the German pharma giant didn’t conduct adequate due diligence before making a ...
Reuters — Bayer won its first trial over claims its Roundup herbicide causes cancer after a California jury found that the herbicide was not a substantial cause of a child’s rare form of non-Hodgkin’s ...
The herbicide Roundup ® contains glyphosate, which may cause cancer. If you or a loved one has cancer after heavily using the toxic weed killer, you may be able to pursue compensation from a Monsanto ...
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...
Bayer has announced plans to shift its efforts away from women’s health to focus on diseases, cardiovascular disease, neurology, oncology and immunology. Bayer AG has agreed to pay a $40 million ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
Beaten in the final of the Europa League, Bayer Leverkusen offered itself a good consolation prize this Saturday by winning the German Cup (1-0). Bayer Leverkusen ends its season on a good note.
Bayer AG (OTC:BAYRY) (OTC:BAYZF) will present detailed results from the Phase 3 studies OASIS 1 and 2, showing that the investigational compound elinzanetant significantly reduced the frequency ...